Finance

Lists
Why is 300573 up 2,75%?
Dive Deeper
300573:SHE
Shenyang Xingqi Pharmaceutical Co Ltd
CNÂĨ34,03
+2,75%
(+0,91) 1D
16 āš•.āšĨ., 9 āŧ‚āšĄāš‡ 41 āš™āšēāš—āšĩ 40 āš§āšīāš™āšēāš—āšĩ GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300573...
Open
CNÂĨ33,40
High
CNÂĨ34,05
Low
CNÂĨ33,40
Mkt. cap
12,05Â āš•āš·āŧ‰
Avg. vol.
4,20 āšĨāŧ‰āšēāš™
Volume
1,04 āšĨāŧ‰āšēāš™
Dividend
2,91%
Quarterly dividend
CNÂĨ0,25
Ex-dividend date
23 āš.āš. 2026
P/E ratio
15,38
52-wk high
CNÂĨ59,07
52-wk low
CNÂĨ32,70
EPS
CNÂĨ2,21
Shares outstanding
354,92 āšĨāŧ‰āšēāš™
No. of employees
2Â āšžāšąāš™
Open
CNÂĨ33,40
High
CNÂĨ34,05
Low
CNÂĨ33,40
Mkt. cap
12,05Â āš•āš·āŧ‰
Avg. vol.
4,20 āšĨāŧ‰āšēāš™
Volume
1,04 āšĨāŧ‰āšēāš™
Dividend
2,91%
Quarterly dividend
CNÂĨ0,25
Ex-dividend date
23 āš.āš. 2026
P/E ratio
15,38
52-wk high
CNÂĨ59,07
52-wk low
CNÂĨ32,70
EPS
CNÂĨ2,21
Shares outstanding
354,92 āšĨāŧ‰āšēāš™
No. of employees
2Â āšžāšąāš™
News stories
From web sources and news partners
Investor's Business Daily
Investor's Business Daily
·
1 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Anthropic Value Doubts Hit Tech Futures; Tesla Roadster Due
MarketBeat
MarketBeat
·
24 āš™āšēāš—āšĩāšāŧˆāš­āš™
StoneX Group (NASDAQ:SNEX) CEO Sells 45,000 Shares of Company Stock
FinancialContent
FinancialContent
·
1 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Kaplan Fox Encourages Qfin Holdings, Inc. (NASDAQ: QFIN) Investors to Contact the Firm Before the Deadline on November 27, 2026
WSJ
WSJ
·
4 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Stocks Gain as Treasury Yields Give Back Some Recent Gains
About Shenyang Xingqi Pharmaceutical Co Ltd
CEO-
Employees2,4Â āšžāšąāš™
Founded24 āšĄ.āš™. 1977
Headquarters-
SectorPharmaceutical industry
Websitesinqi.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
āš.āš. 2025
āš—.āš§. 2025
āšĄ.āš™. 2026
āšĄāšī.āš–. 2026
Revenue
740,99 āšĨāŧ‰āšēāš™
569,12 āšĨāŧ‰āšēāš™
683,34 āšĨāŧ‰āšēāš™
717,54 āšĨāŧ‰āšēāš™
Cost of goods sold
123,12 āšĨāŧ‰āšēāš™
122,47 āšĨāŧ‰āšēāš™
122,64 āšĨāŧ‰āšēāš™
125,94 āšĨāŧ‰āšēāš™
Cost of revenue
123,12 āšĨāŧ‰āšēāš™
122,47 āšĨāŧ‰āšēāš™
122,64 āšĨāŧ‰āšēāš™
125,94 āšĨāŧ‰āšēāš™
Research and development expenses
63,36 āšĨāŧ‰āšēāš™
70,79 āšĨāŧ‰āšēāš™
84,47 āšĨāŧ‰āšēāš™
76,83 āšĨāŧ‰āšēāš™
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
230,42 āšĨāŧ‰āšēāš™
264,11 āšĨāŧ‰āšēāš™
241,35 āšĨāŧ‰āšēāš™
252,92 āšĨāŧ‰āšēāš™
Operating expense
286,99 āšĨāŧ‰āšēāš™
351,25 āšĨāŧ‰āšēāš™
331,32 āšĨāŧ‰āšēāš™
338,13 āšĨāŧ‰āšēāš™
Total operating expenses
410,12 āšĨāŧ‰āšēāš™
473,72 āšĨāŧ‰āšēāš™
453,96 āšĨāŧ‰āšēāš™
464,08 āšĨāŧ‰āšēāš™
Operating income
330,87 āšĨāŧ‰āšēāš™
95,41 āšĨāŧ‰āšēāš™
229,38 āšĨāŧ‰āšēāš™
253,46 āšĨāŧ‰āšēāš™
Other non operating income
-1,22 āšĨāŧ‰āšēāš™
475,40Â āšžāšąāš™
797,23Â āšžāšąāš™
-1,14 āšĨāŧ‰āšēāš™
EBT including unusual items
304,06 āšĨāŧ‰āšēāš™
111,50 āšĨāŧ‰āšēāš™
230,12 āšĨāŧ‰āšēāš™
252,18 āšĨāŧ‰āšēāš™
EBT excluding unusual items
330,73 āšĨāŧ‰āšēāš™
93,98 āšĨāŧ‰āšēāš™
230,10 āšĨāŧ‰āšēāš™
254,28 āšĨāŧ‰āšēāš™
Income tax expense
39,98 āšĨāŧ‰āšēāš™
14,56 āšĨāŧ‰āšēāš™
23,71 āšĨāŧ‰āšēāš™
28,19 āšĨāŧ‰āšēāš™
Effective tax rate
13,15%
13,05%
10,30%
11,18%
Other operating expenses
-10,95 āšĨāŧ‰āšēāš™
20,05 āšĨāŧ‰āšēāš™
4,96 āšĨāŧ‰āšēāš™
7,76 āšĨāŧ‰āšēāš™
Net income
264,08 āšĨāŧ‰āšēāš™
96,95 āšĨāŧ‰āšēāš™
206,41 āšĨāŧ‰āšēāš™
223,99 āšĨāŧ‰āšēāš™
Net profit margin
35,64%
17,03%
30,21%
31,22%
Earnings per share
-
-
-
-
Interest and investment income
462,25Â āšžāšąāš™
399,40Â āšžāšąāš™
408,35Â āšžāšąāš™
453,55Â āšžāšąāš™
Interest expense
-1,00 āšĨāŧ‰āšēāš™
-631,22Â āšžāšąāš™
-481,32Â āšžāšąāš™
-195,66Â āšžāšąāš™
Net interest expenses
-538,91Â āšžāšąāš™
-231,82Â āšžāšąāš™
-72,97Â āšžāšąāš™
257,89Â āšžāšąāš™
Depreciation and amortization charges
-
-
-
-
EBITDA
353,72 āšĨāŧ‰āšēāš™
120,67 āšĨāŧ‰āšēāš™
254,64 āšĨāŧ‰āšēāš™
283,39 āšĨāŧ‰āšēāš™
Gain or loss from assets sale
74,80Â āšžāšąāš™
-52,54Â āšžāšąāš™
-
-7,97Â āšžāšąāš™
AI content may include mistakes. Learn more
āŧāš­āšąāššāš‚āš­āš‡ Google